🇺🇸 Warfarin Sodium Tablets in United States

501 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 501

Most-reported reactions

1. International Normalised Ratio Decreased — 112 reports (22.36%)
2. International Normalised Ratio Increased — 94 reports (18.76%)
3. Product Quality Issue — 61 reports (12.18%)
4. International Normalised Ratio Fluctuation — 57 reports (11.38%)
5. Drug Ineffective — 40 reports (7.98%)
6. Contusion — 31 reports (6.19%)
7. Product Substitution Issue — 31 reports (6.19%)
8. Rash — 26 reports (5.19%)
9. Alopecia — 25 reports (4.99%)
10. Diarrhoea — 24 reports (4.79%)

Source database →

Frequently asked questions

Is Warfarin Sodium Tablets approved in United States?

Warfarin Sodium Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Warfarin Sodium Tablets in United States?

Guangdong Raynovent Biotech Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.